Australia vs Sub-Saharan Africa: Proportion of the target population who received a 3rd dose of
Australia
95.0%
in 2024
Sub-Saharan Africa
63.0%
in 2024
Australia rank
28th
Sub-Saharan Africa rank
25th
Proportion of the target population who received a 3rd dose of over time
- Australia
- Sub-Saharan Africa
How they compare
Australia currently reports 95.0% against 63.0% in Sub-Saharan Africa, a difference of 32.0%.
That makes Australia's figure about 1.5 times Sub-Saharan Africa's.
Across all 16 years both countries report, Australia has been ahead every year.
Australia ranks 28th and Sub-Saharan Africa ranks 25th of 157 countries.
Australia has averaged higher in every one of the 3 decades both report.
Head to head by decade
| Decade | Australia | Sub-Saharan Africa | Difference | Ahead |
|---|---|---|---|---|
| 2000s | 91.0% | 0.0% | 91.0% | Australia |
| 2010s | 92.7% | 45.3% | 47.4% | Australia |
| 2020s | 95.8% | 65.6% | 30.2% | Australia |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher proportion of the target population who received a 3rd dose of, Australia or Sub-Saharan Africa?
- Australia, at 95.0% against 63.0% in Sub-Saharan Africa as of 2024.
- What is the difference in proportion of the target population who received a 3rd dose of between Australia and Sub-Saharan Africa?
- 32.0%, with Australia ahead.
- How many years of comparable data are there for Australia and Sub-Saharan Africa?
- 16 years are reported by both, from 2009 to 2024.
- How do Australia and Sub-Saharan Africa rank globally for proportion of the target population who received a 3rd dose of?
- Australia ranks 28th and Sub-Saharan Africa ranks 25th of 157 countries.
- Where does this data come from?
- United Nations Statistics Division, SDG Global Database, published as Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%). Statizoid refreshes it automatically from the source and publishes the full history for both places.